14. Mark Erlander – Quantitative Detection of Cancer Mutations in Liquid Biopsy Samples (Track 1)
Mark Erlander, Ph.D., CSO, Trovagene Quantitative circulating tumor DNA (ctDNA) detection methodologies enable highly sensitive detection and monitoring of oncogenic mutations in cancer patients. The…